Imaging of uncommon esophageal malignancies

Tirumani, Harika; Rosenthal, Michael H.; Tirumani, Sree Harsha; Shinagare, Atul B.; Krajewski, Katherine M.; Ramaiya, Nikhil H.

doi:10.1111/dote.12208

Cited by 7 publications

(5 citation statements)

References 41 publications

(131 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CT and enhanced CT may provide useful information regarding tumor location, density, relationship with adjacent organs, and metastasis, as well as facilitate the elimination of primary small cell lung cancer. 22 Of course, the final definitive diagnosis still depends on pathological immunohistochemical staining.…”

Section: Diagnosismentioning

confidence: 99%

Progress in the treatment of esophageal neuroendocrine carcinoma

Cai

Cui

2017

Tumour Biol.

View full text Add to dashboard Cite

Esophageal neuroendocrine neoplasms are rare. With the improvement and popularization of diagnostic methods, the morbidity statistics have increased annually in recent years. There are currently no treatment guidelines for esophageal neuroendocrine neoplasms, and surgery is the only cure. This usually involves radical surgery when the tumor is limited to the primary site or when only regional lymph node metastasis occurs. Surgical treatment is key to treating esophageal neuroendocrine neoplasms, but combined treatment with chemotherapy and radiotherapy can significantly improve patient survival. The effect of radiotherapy alone on this disease is poor. However, targeted endocrine therapy can improve endocrine hormone symptoms. The prognosis of patients with esophageal neuroendocrine neoplasms is mainly determined by the pathological stage. With the development of molecular biology techniques, the combination of targeted drugs and traditional chemotherapy is expected to provide novel ideas and directions for the treatment of esophageal neuroendocrine neoplasms in the coming years. In this article, the status of esophageal neuroendocrine tumor treatments was reviewed in detail.

show abstract

Section: Diagnosismentioning

confidence: 99%

Progress in the treatment of esophageal neuroendocrine carcinoma

Cai

Cui

2017

Tumour Biol.

View full text Add to dashboard Cite

show abstract

“…Majority of primary GI lymphomas are DLBCL[ 18 ]. A major risk factor for primary esophageal lymphoma is immunosuppression, such as HIV infection[ 19 ]. Radiologic features of primary esophageal lymphoma are ulceration, stenosis, polypoid masses, aneurysmal dilatation and TEF, which are non-specific[ 19 , 20 ].…”

Section: Discussionmentioning

confidence: 99%

Primary esophageal diffuse large B cell lymphoma presenting with tracheoesophageal fistula: A rare case and review

Teerakanok

DeWitt

Juarez

et al. 2017

WJGO

View full text Add to dashboard Cite

Primary non-Hodgkin lymphomas in the esophagus are rare. Tracheoesophageal fistulas mainly arise from solid esophageal carcinoma or mediastinal malignancies. Our patient presented with cough, dysphagia and weight loss, and upon initial computed tomography imaging and esophagogastroduodenoscopy, a malignant mass in the middle third of esophagus with tracheoesophageal fistula was found. The location of the mass and presence of malignant tracheoesophageal fistula were strongly suggestive of squamous cell carcinoma. However, tumor biopsy revealed diffuse large B-cell lymphoma. This case report details a rare incident of a primary diffuse large B-cell lymphoma presented as tracheoesophageal fistula and reviews previous literature.

show abstract

“…Considering the clinical presentation, EGDS with biopsy sampling should be the first-line evaluation procedure: On endoscopy, oesophageal NETs appear as polypoid or nodular submucosal masses, while oesophageal NECs appear as large, infiltrative and ulcerated lesions[ 68 , 71 , 72 ]. The diagnostic assessment is completed by EUS, contrast-enhanced CT and MRI[ 73 ].…”

Section: Rare Primitive Oesophageal Malignant Tumours Of Epithelial Omentioning

confidence: 99%

Histopathological landscape of rare oesophageal neoplasms

Businello

Pozzo

Sbaraglia

et al. 2020

WJG

View full text Add to dashboard Cite

The landscape of neoplastic pathology of the oesophagus is dominated by malignancies of epithelial origin, in particular by oesophageal adenocarcinoma and oesophageal squamous cell carcinoma. However, several other histopathological variants can be distinguished, some associated with peculiar histopathological profiles and prognostic behaviours and frequently underrecognized in clinical practice. The aim of this review is to provide a comprehensive characterization of the main morphological and clinical features of these rare variants of oesophageal neoplastic lesions.

show abstract

Imaging of uncommon esophageal malignancies

Cited by 7 publications

References 41 publications

Progress in the treatment of esophageal neuroendocrine carcinoma

Progress in the treatment of esophageal neuroendocrine carcinoma

Primary esophageal diffuse large B cell lymphoma presenting with tracheoesophageal fistula: A rare case and review

Histopathological landscape of rare oesophageal neoplasms

Contact Info

Product

Resources

About